Evidence map›Paper›PMID 39006021›Full record

ArticlePeerJ2024

The usefulness of peri-trigger female reproductive hormones (delta-FRH) in predicting oocyte maturation in normal ovarian reserve patients who received

Lina He, Qing Xu, Fuming Wan, Li Hao, Yamin Qiu, Xu Ran, Jie Lin, Wei Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PeerJ, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lina HeDepartment of Reproductive Medicine, Zigong Hospital of Women and Children Health Care, Zigong, Sichuan, China.
Qing XuDepartment of Reproductive Medicine, Zigong Hospital of Women and Children Health Care, Zigong, Sichuan, China.
Fuming WanDepartment of Reproductive Medicine, Zigong Hospital of Women and Children Health Care, Zigong, Sichuan, China.
Li HaoDepartment of Reproductive Medicine, Zigong Hospital of Women and Children Health Care, Zigong, Sichuan, China.
Yamin QiuDepartment of Reproductive Medicine, Zigong Hospital of Women and Children Health Care, Zigong, Sichuan, China.
Xu RanDepartment of Reproductive Medicine, Zigong Hospital of Women and Children Health Care, Zigong, Sichuan, China.
Jie LinDepartment of Reproductive Medicine, Zigong Hospital of Women and Children Health Care, Zigong, Sichuan, China.
Wei ChenDepartment of Urology, Zigong Fourth People's Hospital, Zigong, Sichuan, China.

Funding

Natural Science Foundation of SichuanZigong Heath Commission Science ProjectZigong Key Scientific and Technology Project
6 · The paper itself

Abstract

Objectives: To evaluate the efficacy of peri-trigger female reproductive hormones (FRHs) in the prediction of oocyte maturation in normal ovarian reserve patients during the Materials and Methods: A hospital database was used to extract data on IVF-ET cases from January 2020 to September 2021. The levels of female reproductive hormones, including estradiol (E2), luteinizing hormone (LH), progesterone (P), and follicle-stimulating hormone (FSH), were initially evaluated at baseline, the day of the trigger, the day after the trigger, and the day of oocyte retrieval. The relative change in E2, LH, P, FSH between time point 1 (the day of trigger and baseline) and time point 2 (the day after the trigger and day on the trigger) was defined as E2_RoV1/2, LH_RoV1/2, P_RoV1/2, and FSH_RoV1/2, respectively. Univariable and multivariable regression were performed to screen the peri-trigger FRHs for the prediction of oocyte maturation. Results: A total of 118 patients were enrolled in our study. Univariable analysis revealed significant associations between E2_RoV1 and the rate of MII oocytes in the GnRH-agonist protocol group ( Conclusions: P_RoV2 showed significant predictive value for oocyte maturation in both GnRH-agonist and GnRH-antagonist protocol groups, which enhances the understanding of evaluating oocyte maturation and inform individualized treatment protocols in controlled ovarian hyperstimulation during IVF-ET for normal ovarian reserve patients.

Indexed as

Embryo TransferEstradiolFertilization in VitroFollicle Stimulating HormoneLuteinizing HormoneOvarian ReserveOvulation InductionProgesteroneAdultFemaleHumansOocyte RetrievalOocytesOogenesisPregnancyRetrospective StudiesEstradiolFollicle Stimulating HormoneLuteinizing HormoneProgesteroneBiomarkerFemale reproductive hormoneIn vitro fertilization-embryo transferOocyte maturityPeri-trigger management

Identifiers

PMID39006021
PMCPMC11246619

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.